Shares of BeyondSpring Inc. (NASDAQ:BYSI – Get Free Report) dropped 1.4% during trading on Friday . The stock traded as low as $1.71 and last traded at $1.71. Approximately 4,718 shares traded hands during trading, a decline of 69% from the average daily volume of 15,068 shares. The stock had previously closed at $1.74.
BeyondSpring Price Performance
The business’s 50-day moving average is $1.69 and its 200 day moving average is $1.96.
Hedge Funds Weigh In On BeyondSpring
An institutional investor recently bought a new position in BeyondSpring stock. Renaissance Technologies LLC acquired a new stake in BeyondSpring Inc. (NASDAQ:BYSI – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 12,500 shares of the company’s stock, valued at approximately $30,000. 40.29% of the stock is owned by institutional investors.
About BeyondSpring
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
See Also
- Five stocks we like better than BeyondSpring
- What is Put Option Volume?
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Investing in Construction Stocks
- 3 Buy-and-Hold Stocks for Long-Term Growth
- What Does a Stock Split Mean?
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
